Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VISTA-16 Trial: Evaluation of the Safety and Efficacy of Short-Term A-002 Treatment in Subjects With Acute Coronary Syndromes

NCT01130246 is registered in ClinicalTrials.gov with Anthera Pharmaceuticals as lead sponsor.

NCT NCT01130246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01130246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VISTA-16 Trial: Evaluation of the Safety and Efficacy of Short-Term A-002 Treatment in Subjects With Acute Coronary Syndromes
Lead sponsor
Anthera Pharmaceuticals
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2010
Completion date
March 31, 2012
Enrollment
5,189 (actual)
Sites
362

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome